MEDICINA
Departamento
United States Food and Drug Administration
Silver Spring, Estados UnidosPublicaciones en colaboración con investigadores/as de United States Food and Drug Administration (7)
2022
-
Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies
The Lancet. Haematology, Vol. 9, Núm. 5, pp. e374-e384
2021
-
Minimal residual disease in Myeloma: Application for clinical care and new drug registration
Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212
2018
-
Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies
The Lancet Haematology, Vol. 5, Núm. 11, pp. e563-e598
2010
-
Human peripheral blood B-Cell compartments: A crossroad in B-cell traffic
Cytometry Part B - Clinical Cytometry, Vol. 78, Núm. SUPPL. 1
2007
-
ZAP70 editorial: A follow-up to the special issue
Cytometry Part B - Clinical Cytometry
2006
-
ZAP-70 in CLL: Towards standardization of a biomarker for patient management: History of clinical cytometry special issue
Cytometry Part B - Clinical Cytometry
1998
-
Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates
Journal of Clinical Microbiology, Vol. 36, Núm. 4, pp. 958-964